RxDoctor Payments Data

Amy Dowdy, DO

Family Medicine · Beckley, WVNPI 1457443707

Payments from drug & device makers

$274in general payments, 2019–2025

Across 14 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$61
  • Novo Nordisk$50
  • Tonix Medicines, Inc.$48
  • AstraZeneca$39
  • Abbott$23
  • Lilly USA, LLC$19
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$274100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie3$61
Novo Nordisk3$50
Tonix Medicines, Inc.2$48
AstraZeneca2$39
Abbott1$23
Lilly USA, LLC1$19
Pfizer1$19
Dexcom, Inc.1$16

How this compares

$274 in reported general payments places this provider in the 45th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$17,728
Medicare patients
234
Services billed
1,540

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide122$189,760
TrulicityDulaglutide114$135,681
JardianceEmpagliflozin97$126,400
MounjaroTirzepatide90$99,143
EliquisApixaban77$93,752
JanuviaSitagliptin Phosphate59$86,167
XareltoRivaroxaban42$60,495
TradjentaLinagliptin34$45,646
LinzessLinaclotide35$40,732
Tresiba Flextouch U-100Insulin Degludec53$37,613
TivicayDolutegravir Sodium11$28,489
DescovyEmtricitabine/Tenofov Alafenam11$27,243
BrilintaTicagrelor18$22,083
EntrestoSacubitril/Valsartan16$19,627
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$19,423

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$19$234,824204 claims
Novo NordiskOzempic$50$189,760122 claims
PfizerEliquis, Paxlovid$19$96,61089 claims
AbbVieLinzess, Synthroid$61$53,193142 claims
AstraZenecaBrilinta$39$22,08318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Beckley

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →